Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Short View of Leukemia Diagnosis and Treatment in Iran



Azad M1 ; Biniaz RB1 ; Goudarzi M2 ; Mobarra N3 ; Alizadeh S4 ; Nasiri H5 ; Fard AD6 ; Kaviani S7 ; Moghadasi MH7 ; Sarookhani MR1 ; Vatanmakan M4 ; Sahmani M8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical laboratory sciences, Qazvin University of Medical Sciences, Qazvin, Iran
  2. 2. Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran
  3. 3. Department of Biochemistry, Metabolic Disorders Research Center, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  4. 4. Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Hematology-Oncology and Stem cell Transplantation Research Center, Tehran university of Medical Science, Tehran, Iran
  6. 6. Sarem Cell Research Center, Sarem Women’s Hospital, Tehran, Iran
  7. 7. Department of Hematology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  8. 8. Department of Clinical Biochemistry, Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran

Source: International Journal of Hematology-Oncology and Stem Cell Research Published:2015

Abstract

Background: Early diagnosis and treatment of leukemia patients remains a fundamental aim in clinical oncology, especially in developing country. Present study highlights the basic requirements of these patients in Iran. Better understanding of these issues may lead to improve the healthcare standards toward leukemia diagnosis and treatment. Methods: This descriptive study included 101 specialists in hematology-oncology and pathology serving in oncology centers. The participants were then asked to fill out a standard questionnaire on the issues around diagnosis and treatment of blood malignancies. Results: According to specialists, unfair distribution of facilities across the country, delayed diagnosis of disease, absence of psychological support for patients, and insufficient financial support were the main reasons of inappropriate diagnosis and treatment in leukemia patients. Conclusions: Our results show that making an amendment to health policies by preparing well-equipped medical centers in all provinces, improving the morale of patients through consultation during the process of treatment, and above all, subsiding leukemia patients' financial problems will promote the health standard regarding the leukemia diagnosis and treatment in Iran. © 2015, Tehran University of Medical Sciences (TUMS). All rights reserved.